ENANTIOSELECTIVE DISPOSITION OF 2-ARYLPROPIONIC ACID NONSTEROIDAL ANTIINFLAMMATORY DRUGS .2. 2-PHENYLPROPIONIC ACID PROTEIN-BINDING

被引：0
作者：
JONES, ME
SALLUSTIO, BC
PURDIE, YJ
MEFFIN, PJ
机构：
[1] FLINDERS UNIV S AUSTRALIA,DEPT CLIN PHARMACOL,BEDFORD PK,SA 5042,AUSTRALIA
[2] FLINDERS UNIV S AUSTRALIA,DEPT ANAT & HISTOL,BEDFORD PK,SA 5042,AUSTRALIA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1986年 / 238卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：288 / 294
页数：7
相关论文
共 19 条
[1]  
BIRKETT DJ, 1977, MOL PHARMACOL, V13, P987
[2]  
CHEN RF, 1967, J BIOL CHEM, V242, P173
[3]   THE IMPORTANCE OF STEREOCHEMISTRY IN THE CLINICAL PHARMACOKINETICS OF THE 2-ARYLPROPIONIC ACID NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [J].
HUTT, AJ ;
CALDWELL, J .
CLINICAL PHARMACOKINETICS, 1984, 9 (04) :371-373
[4]  
HUTT AJ, 1983, J PHARM PHARM, V35, P963
[5]   The mode of oxidation of fatty acids with branched chains. II. The fate in the body of hydratropic, tropic, atrolactic and atropic acids together with phenylacetaldehyde. [J].
Kay, HD ;
Raper, HS .
BIOCHEMICAL JOURNAL, 1922, 16 (04) :465-474
[6]  
MEFFIN PJ, 1986, J PHARMACOL EXP THER, V238, P280
[7]   ALTERATIONS IN PREDNISOLONE DISPOSITION AS A RESULT OF TIME OF ADMINISTRATION, GENDER AND DOSE [J].
MEFFIN, PJ ;
BROOKS, PM ;
SALLUSTIO, BC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :395-404
[8]  
MEFFIN PJ, 1983, J PHARMACOL EXP THER, V227, P732
[9]  
RENDIC S, 1980, FARMACO-ED SCI, V35, P51
[10]   ENANTIOSPECIFIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF 2-PHENYLPROPIONIC ACID, KETOPROFEN AND FENOPROFEN [J].
SALLUSTIO, BC ;
ABAS, A ;
HAYBALL, PJ ;
PURDIE, YJ ;
MEFFIN, PJ .
JOURNAL OF CHROMATOGRAPHY, 1986, 374 (02) :329-337
12